Corpus Intelligence JOHNS HOPKINS BAYVIEW MED. CTR. 2026-04-26 05:11 UTC
JOHNS HOPKINS BAYVIEW MED. CTR.
CCN 210029 — BALTIMORE, MD — 424 beds
🛡️ Public data only — no PHI permitted on this instance.
HOSP

JOHNS HOPKINS BAYVIEW MED. CTR.

CCN 210029|LOC BALTIMORE, MD|BEDS 424|NPR $654.4M|MARGIN -17.1%
45
D
SeekingChartis Score
INVESTMENT THESIS
Buy: JOHNS HOPKINS BAYVIEW MED. CTR.
62
/ 100 (B)
+$48.2M
EBITDA Uplift
+736bps
Margin Δ
0.0%
Op Margin
$654.4M
Revenue
—
Realization
—
Peer Rank
SIGNAL STRENGTH
Margin
0.0%
Safety
48%
CATALYSTS
▲RCM uplift of $48.2M (+736bps)
▲Platform-sized facility
RISKS
▼Elevated distress risk (52%)
Buy — solid fundamentals with identifiable value creation levers. Proceed to detailed diligence.
Peer AnalysisEBITDA BridgeData RoomIC MemoML Detail
$654.4M
Net Patient Revenue
-17.1%
Operating Margin
$-112.0M
Net Income
424
Licensed Beds
$1,543K
Revenue per Bed
$766.3M
Operating Expenses

Payer Mix

PYR
■ MEDICARE · 35%■ MEDICAID · 15%■ COMMERCIAL · 50%

Score Breakdown

SCComposite · 45/100
ComponentScoreMax%Distribution
Market Position273577%
Financial Health32514%
Operational Quality0200%
Competitive Moat62028%

Comparable Hospitals

CMP
CCNHospitalBedsNPR
210001MERITUS MEDICAL CENTER265$0M
210002UNIVERSITY OF MARYLAND MED SYS779$0M
210003UNIV OF MD CAPITAL REGION MED CTR220$0M
210004HOLY CROSS HOSPITAL399$0M
210005FREDERICK MEMORIAL HOSPITAL279$0M

Team Notes

NOTE0 entries

Actions

ACT
WFDiligence Workflow
Competitive IntelEBITDA BridgeData RoomIC MemoScenarios
AIDeep Analysis
ML AnalysisDemand3-Year HistoryStatsBayesian
FINFinancial Models
DCFLBO3-StatementReturnsMarketDenial
MORE IN MDStart Diligence · creates a deal from HCRIS